• COVID-19: Clinical Resources & Patient Education

    Updated September 10, 2021

    Interim Guidance for Clinical Management


    Options for Treatment

    • CDC Issues Ivermectin Health Alert: Taking ivermectin for COVID-19 can cause severe illness when taken outside of its intended use or when taking veterinary formulations. The CDC issued a health alert warning about the rise in prescriptions for ivermectin and the increased number of calls to poison centers. It is important to note that ivermectin can cause severe illness when taken outside of its intended use or when taking veterinary formulations.

      Ivermectin is not recommended for prevention or treatment of COVID-19. Current NIH Treatment Guidelines state that there is insufficient evidence to recommend either for or against the use of ivermectin for the treatment of COVID-19 outside of clinical trials.  The AAFP urges caution in prescribing therapeutics for treatment or prevention of COVID-19 that have not been approved or authorized by the U.S. Food and Drug Administration (FDA) based on substantial evidence for safety and efficacy.

      The FDA has issued the following statements: FDA has not approved or issued an Emergency Use Authorization for ivermectin for use in treating or preventing COVID-19 in humans. Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical formulations for head lice and skin conditions. Ivermectin is not an anti-viral. For additional information see the FDA Information Page  and the FDA Ivermectin FAQ.

      • Taking large doses of this drug is dangerous and can cause serious harm.  
      • If you have a prescription for ivermectin for an FDA-approved use, get it from a legitimate source and take it exactly as prescribed.  
      • Never use medications intended for animals on yourself. Ivermectin preparations for animals are very different from those approved for humans.  

    Testing and Diagnosis

    • AAFP COVID-19 Testing Resources Web Page: This web page provides information on who to test, access and availability, types of tests, results, impact of new variants, specimen collection, and coding and billing. (Updated 4/20/21)


    Considerations for Special Populations


    Infection Control/Emergency Preparedness


    Patient Education